pub 30-day FRN

pub 30-day FRN2022-08976.pdf

Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIAID)

pub 30-day FRN

OMB: 0925-0668

Document [pdf]
Download: pdf | pdf
25031

Federal Register / Vol. 87, No. 81 / Wednesday, April 27, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Institute on Aging; Notice of
Closed Meeting

Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(NIAID)

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; ADRD
Program Project.
Date: June 1, 2022.
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Greg Bissonette, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–1622, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)

AGENCY:

Institute of Allergy and Infectious
Diseases (NIAID), National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NIAID), 0925–0668,
Expiration Date 4/30/2022,
EXTENSION, National Institute of
Allergy and Infectious Diseases (NIAID).
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
proposed information collection activity
provides a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the Administration’s
commitment to improving service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide information
about the NIAID’s customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
NIAID and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2511.

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Dated: April 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.

Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Brandie
Taylor, Supervisory Program Analyst,
Office of Strategic Planning, Initiative
Development and Analysis, 5601
Fishers Lane, Rockville, Maryland
20892 or call non-toll-free number (240)
669–0296 or Email your request,
including your address to: taylorbr@
niaid.nih.gov.

[FR Doc. 2022–08969 Filed 4–26–22; 8:45 am]

SUPPLEMENTARY INFORMATION:

ADDRESSES:

This
proposed information collection was
previously published in the Federal
Register on February 10, 2022, pages
7848–7849 (87 FR 7848) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. National

BILLING CODE 4140–01–P

lotter on DSK11XQN23PROD with NOTICES1

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of collection
Customer satisfaction surveys .........................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Individual Brief Interviews ................................................................................

VerDate Sep<11>2014

17:38 Apr 26, 2022

Jkt 256001

PO 00000

Frm 00098

Fmt 4703

Sfmt 4703

Annual
frequency per
response

4,000
50
50

E:\FR\FM\27APN1.SGM

1
1
1

27APN1

Hours per
response
30/60
90/60
15/60

Total hours
2,000
75
13

25032

Federal Register / Vol. 87, No. 81 / Wednesday, April 27, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents

Type of collection

Hours per
response

Total hours

Focus Groups ..................................................................................................
Pilot testing surveys .........................................................................................
Conferences and Training Pre- and Post-surveys ..........................................
Website or Software Usability Tests ................................................................

30
25
500
50

1
1
1
1

2
30/60
30/60
2

60
13
250
100

Total ..........................................................................................................

4,705

........................

........................

2,511

Dated: April 22, 2022.
Brandie K. Taylor Bumgardner,
Project Clearance Liaison, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health.

93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)

[FR Doc. 2022–08976 Filed 4–26–22; 8:45 am]

Dated: April 22, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.

BILLING CODE 4140–01–P

[FR Doc. 2022–08959 Filed 4–26–22; 8:45 am]
BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Duchenne
Muscular Dystrophy Therapy.
Date: May 4, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, [email protected].
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,

17:38 Apr 26, 2022

Jkt 256001

Dated: April 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

VerDate Sep<11>2014

Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)

[FR Doc. 2022–08953 Filed 4–26–22; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

lotter on DSK11XQN23PROD with NOTICES1

Annual
frequency per
response

National Institutes of Health

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institute of General Medical
Sciences; Notice of Closed Meeting

National Institutes of Health

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Review; Centers of Biomedical
Research Excellence (COBRE) (P20)
Applications.
Date: July 18–19, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of General
Medical Science, Natcher Bldg. 45, Center
Drive Bethesda, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Manas Chattopadhyay,
National Institutes of Health, 45 Center Dr.,
Bethesda, MD 20872, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,

PO 00000

Frm 00099

Fmt 4703

Sfmt 4703

National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Biomedical Research Study
Section.
Date: June 7, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Philippe Marmillot, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, National Institutes of Health
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive, Room
2118, MSC 6902, Bethesda, MD 20892, 301–
443–2861, [email protected].

E:\FR\FM\27APN1.SGM

27APN1


File Typeapplication/pdf
File Modified2022-04-27
File Created2022-04-27

© 2024 OMB.report | Privacy Policy